Biomx Inc. (PHGE) — 8-K Filings

8-K Filings (26)

• BiomX Inc. Files 8-K with Press Release — Apr 16, 2026 Risk: low
  BiomX Inc. filed an 8-K on April 16, 2026, reporting under Regulation FD and other events. The filing includes a press release dated April 16, 2026, and various
• BiomX Inc. Files 8-K on Material Agreements — Apr 1, 2026 Risk: medium
  BiomX Inc. filed an 8-K on April 1, 2026, reporting the entry into a material definitive agreement. The filing includes exhibits such as an unsecured convertibl
• BiomX Inc. Files 8-K: Material Agreement, Equity Sales — Dec 29, 2025 Risk: medium
  BiomX Inc. filed an 8-K on December 29, 2025, reporting on events that occurred on December 26, 2025. The filing indicates an entry into a material definitive a
• BiomX Inc. Files 8-K: Other Events Reported — Dec 11, 2025 Risk: medium
  BiomX Inc. filed an 8-K on December 11, 2025, reporting an 'Other Events' item. The company, formerly known as Chardan Healthcare Acquisition Corp. until April
• BiomX Inc. Files 8-K: Other Events Reported — Dec 8, 2025 Risk: low
  BiomX Inc. filed an 8-K on December 8, 2025, reporting an event under 'Other Events'. The company, formerly known as Chardan Healthcare Acquisition Corp. until
• 8-K Filing — Nov 25, 2025
• BiomX Inc. Files 8-K on Security Holder Rights and Bylaws — Nov 17, 2025 Risk: medium
  BiomX Inc. filed an 8-K on November 17, 2025, reporting material modifications to the rights of security holders and amendments to its articles of incorporation
• BiomX Inc. Files 8-K — Oct 17, 2025 Risk: low
  BiomX Inc. filed an 8-K on October 17, 2025, reporting an "Other Events" item. The filing does not contain specific details about the event, dollar amounts, or
• BiomX Inc. Files 8-K for Other Events — Aug 19, 2025 Risk: medium
  BiomX Inc. filed an 8-K on August 19, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amou
• BiomX Inc. Files 8-K on Shareholder Nominations — Jul 30, 2025 Risk: medium
  BiomX Inc. filed an 8-K on July 30, 2025, to report shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing indicates that BiomX Inc., formerly
• BiomX Inc. Files 8-K with Regulatory Updates — Jul 8, 2025 Risk: low
  BiomX Inc. filed an 8-K on July 8, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Chardan Heal
• 8-K Filing — Jun 9, 2025
• BiomX Inc. Reports on Shareholder Vote Matters — Apr 23, 2025 Risk: low
  BiomX Inc. filed an 8-K on April 23, 2025, reporting on matters submitted to a vote of its security holders on April 21, 2025. The company, formerly known as Ch
• BiomX Inc. Files 8-K with Financials and Other Events — Mar 31, 2025 Risk: low
  BiomX Inc. filed an 8-K on March 31, 2025, reporting on various events. The filing includes financial statements and exhibits, and also serves as a Regulation F
• BiomX to be Acquired by Adaptive Phage Therapeutics — Mar 5, 2025 Risk: medium
  BiomX Inc. announced on February 27, 2025, that it has entered into a definitive agreement to be acquired by Adaptive Phage Therapeutics, Inc. The transaction i
• 8-K Filing — Feb 27, 2025
• BiomX Inc. Files 8-K for "Other Event" — Dec 16, 2024 Risk: low
  BiomX Inc. filed an 8-K on December 16, 2024, reporting an "Other Event." The filing does not contain specific details about the event itself, but it confirms t
• BiomX Inc. Faces Delisting Notice — Oct 15, 2024 Risk: high
  BiomX Inc. filed an 8-K on October 15, 2024, to report a notice of delisting or failure to satisfy a continued listing rule. The company was formerly known as C
• BiomX Inc. Reports Trading Information on NYSE American — Sep 26, 2024 Risk: low
  BiomX Inc. reported on September 26, 2024, that its common stock and units, each consisting of one share of common stock and one warrant, are trading on the NYS
• BiomX Inc. Files 8-K on Security Holder Rights — Aug 16, 2024 Risk: low
  BiomX Inc. filed an 8-K on August 16, 2024, reporting material modifications to security holder rights and amendments to its articles of incorporation. The fili
• BiomX Faces NYSE Delisting Warning — Jul 29, 2024 Risk: high
  BiomX Inc. announced on July 23, 2024, that it received a notice from the NYSE American indicating it is not in compliance with continued listing standards. The
• BiomX Inc. Files 8-K: Director Changes & Corporate Updates — Jul 9, 2024 Risk: medium
  BiomX Inc. filed an 8-K on July 9, 2024, reporting on several key events including the departure of directors, election of new directors, and changes in officer
• BiomX Inc. Reports Director, Officer, and Bylaw Changes — Apr 15, 2024 Risk: medium
  BiomX Inc. filed an 8-K on April 15, 2024, reporting events that occurred on April 11, 2024. The filing indicates changes related to the departure and election
• BiomX Inc. Files 8-K on Financials — Apr 3, 2024 Risk: medium
  BiomX Inc. filed an 8-K on April 3, 2024, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The comp
• BiomX Inc. Files 8-K on Asset Deals and Equity Sales — Mar 18, 2024 Risk: medium
  BiomX Inc. filed an 8-K on March 18, 2024, reporting on several key events including the completion of an acquisition or disposition of assets, unregistered sal
• BiomX Inc. Files 8-K for Equity Sale — Mar 6, 2024 Risk: medium
  BiomX Inc. announced on March 6, 2024, that it entered into a material definitive agreement related to the unregistered sale of equity securities. The company,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX